Biogaia AB OMXSTO:BIOG_B:
BIOGAIA RESEARCH CONFIRMS EFFECTIVENESS OF PATENTED LONGEVITYGUARD TECHNOLOGY IN EXTENDING PROBIOTIC SHELF LIFE
Biogaia Research Confirms Effectiveness Longevityguard Technology
Watch BioGaia's latest callBiogaia (Stockholm:BIOG B) Q2 2026 Earnings Call · Replay · Jul 17Read the transcript of Biogaia (Stockholm:BIOG B) Q2 2026 Earnings CallEarlier from BioGaia
- BioGaia Exercises Option To Acquire Remaining Shares In Nutraceutics
- BioGaia Extends Distribution Partnership With Ewopharma
- BIOG_B: Q4 organic sales up 32%, EBIT margin 27%, and direct markets now 40% of sales
- BioGaia's prelim Q4 sales rise 21%, margins expand
- BIOG_B: Sales up 7%, EBIT margin 26%, direct markets and innovation drive future growth
Later from BioGaia
All BioGaia news releasesFollow BioGaia into a list and get an email when it puts out news.
Follow BioGaia